1National Institute of Health, Tokyo, Japan.
Cellular oncogene activation drives human cancers. Inhibiting oncogene products, like tyrosine kinases with Herbimycin A, offers potential cancer treatments, with ongoing research for Ras and Myc inhibitors.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science: